Promis Neurosciences logo

Promis Neurosciences Share Price (NASDAQ: PMN)

$0.53

Live

Last updated on

Check the interactive Promis Neurosciences Stock chart to analyse performance

Promis Neurosciences stock performance

as on August 28, 2025 at 11:39 pm IST

  • Today's Low:$0.53
    Today's High:$0.55

    Day's Volatility :3.64%

  • 52 Weeks Low:$0.38
    52 Weeks High:$1.59

    52 Weeks Volatility :76.1%

Promis Neurosciences Stock Returns

PeriodPromis Neurosciences IncIndex (Russel 2000)
3 Months
5.71%
0.0%
6 Months
-27.43%
0.0%
1 Year
-60.19%
0.0%
3 Years
-90.64%
-6.9%

Promis Neurosciences Inc Key Stats

Check Promis Neurosciences key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.53
Open
$0.545
Today's High
$0.55
Today's Low
$0.52
Market Capitalization
$28.4M
Today's Volume
$236.1K
52 Week High
$1.59
52 Week Low
$0.38
Revenue TTM
$7.6K
EBITDA
$-13.3M
Earnings Per Share (EPS)
$-0.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-19.56%

Stock Returns calculator for Promis Neurosciences Stock including INR - Dollar returns

The Promis Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Promis Neurosciences investment value today

Current value as on today

₹43,912

Returns

₹56,088

(-56.09%)

Returns from Promis Neurosciences Stock

₹60,448 (-60.45%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Promis Neurosciences Stock

-90%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Promis Neurosciences Stock from India on INDmoney has decreased by -90% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Promis Neurosciences Inc

  • Name

    Holdings %

  • Great Point Partners LLC

    8.09%

  • Armistice Capital, LLC

    6.54%

  • Sphera Funds Management Ltd.

    5.81%

  • Ally Bridge Group (NY) LLC

    4.08%

  • Altium Capital Management, LP

    1.76%

  • Allostery Investments LP

    0.71%

Analyst Recommendation on Promis Neurosciences Stock

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 6 Wall street analysts offering stock ratings for Promis Neurosciences(by analysts ranked 0 to 5 stars)

Promis Neurosciences Share Price Target

What analysts predicted

Upside of 1040.17%

Target:

$6.04

Current:

$0.53

Promis Neurosciences share price target is $6.04, a slight Upside of 1040.17% compared to current price of $0.53 as per analysts' prediction.

Promis Neurosciences Stock Insights

  • Price Movement

    In the last 7 days, PMN stock has moved down by -2.8%
  • PMN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 122.0%
  • PMN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 205.6%
  • Price to Sales

    ForPMN every $1 of sales, investors are willing to pay $537.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Promis Neurosciences Technicals Summary

Sell

Neutral

Buy

Promis Neurosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Promis Neurosciences Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Promis Neurosciences Inc logo
-36.51%
-27.43%
-60.19%
-90.64%
-94.23%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
-1.83%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
91.56%
61.8%
117.28%
242.42%

About Promis Neurosciences Inc

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's Disease; PMN267 for treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.
Organization
Promis Neurosciences
Employees
7
CEO
Mr. Neil K. Warma M.B.A.
Industry
Miscellaneous

Key Management of Promis Neurosciences Inc

NameTitle
Mr. Eugene W. Williams
Co-Founder & Chairman
Mr. Neil K. Warma M.B.A.
CEO, President, Compliance Officer & Director
Dr. Neil R. Cashman M.D.
Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
Mr. Daniel E. Geffken M.B.A.
Chief Financial Officer
Dr. Johanne Kaplan Ph.D.
Chief Development Officer
Dr. David Wishart Ph.D.
Chief Physics Officer
Mr. Dennis Chen Ph.D.
Head of Manufacturing & Senior Consultant
Dr. Larry Douglas Altstiel M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in PMN Stock from India :

What is Promis Neurosciences share price today?

Promis Neurosciences share price today is $0.53 as on . Promis Neurosciences share today touched a day high of $0.55 and a low of $0.53.

What is the 52 week high and 52 week low for Promis Neurosciences share?

Promis Neurosciences share touched a 52 week high of $1.59 and a 52 week low of $0.38. Promis Neurosciences stock price today i.e. is trending at $0.53, lower by 66.67% versus the 52 week high.

How to invest in Promis Neurosciences Stock (PMN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Promis Neurosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Promis Neurosciences Shares that will get you 2.8302 shares as per Promis Neurosciences share price of $0.53 per share as on August 28, 2025 at 11:39 pm IST.

What is the minimum amount required to buy Promis Neurosciences Stock (PMN) from India?

Indian investors can start investing in Promis Neurosciences (PMN) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Promis Neurosciences stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Promis Neurosciences share’s latest price of $0.53 as on August 28, 2025 at 11:39 pm IST, you will get 18.8679 shares of Promis Neurosciences. Learn more about fractional shares .

What are the returns that Promis Neurosciences has given to Indian investors in the last 5 years?

Promis Neurosciences stock has given -94.23% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?